Conversion of salt halides to nitrate salts
    6.
    发明授权
    Conversion of salt halides to nitrate salts 有权
    将卤化盐转化成硝酸盐

    公开(公告)号:US08063228B1

    公开(公告)日:2011-11-22

    申请号:US12902428

    申请日:2010-10-12

    CPC classification number: C07D249/10

    Abstract: Methods of preparing heterocyclic triazolium-based nitrate salts by a streamlined process are provided. Such salts offer energetic performance as well as pharmaceutical potential.

    Abstract translation: 提供了通过流线型制备杂环三唑鎓基硝酸盐的方法。 这些盐提供了精力充沛的表现以及制药潜力。

    Preparation of substituted-1,2,3-triazoles
    7.
    发明授权
    Preparation of substituted-1,2,3-triazoles 失效
    取代-1,2,3-三唑的制备

    公开(公告)号:US07550601B1

    公开(公告)日:2009-06-23

    申请号:US11203578

    申请日:2005-08-15

    CPC classification number: C07D249/04

    Abstract: The invention provides a high yield/isomerically pure synthesis of new 1-amino-3-substituted-1,2,3-triazolium salts and their subsequent transformation into isomerically pure 1-substituted-1,2,3-triazoles. These new 1-amino-3-substituted-1,2,3-triazolium salts are easily isolated and can be stored at ambient conditions with no degradation or isomerization. These quarternary salts are easily converted with appropriate silver salts to a wide array of new quarternary salts with various anions, with many of these new salts having melting points below 100 C, classifying them as ionic liquids. Subsequent diazotization of these 1-amino-3-substituted-1,2,3-triazolium salts results in high yields of isomerically pure 1-substituted-1,2,3-triazoles, that until this invention were problematic to make pure without tedious reagents or workup procedures. Both classes of materials (1-amino-3-substituted-1,2,3-triazolium salts as well as 1-substituted-1,2,3-triazoles) should be of high interest as these classes of materials are known to be very important pharmaceutical materials for a wide array of medical and agricultural applications as well as possible propellant applications.

    Abstract translation: 本发明提供了新的1-氨基-3-取代-1,2,3-三唑鎓盐的高产率/异构纯合成,并且随后转化为异构纯的1-取代-1,2,3-三唑。 这些新的1-氨基-3-取代-1,2,3-三唑鎓盐易于分离,并且可以在没有降解或异构化的环境条件下储存。 这些季盐易于用适当的银盐转化成各种各种阴离子的新季盐,其中许多这些新盐的熔点低于100℃,将它们分类为离子液体。 随后的这些1-氨基-3-取代-1,2,3-三唑鎓盐的重氮化导致异构纯的1-取代-1,2,3-三唑的高产率,直到本发明是有问题的,使纯净而不乏味 试剂或后处理程序。 两类材料(1-氨基-3-取代-1,2,3-三唑鎓盐以及1-取代-1,2,3-三唑)应该是高度兴趣的,因为这些类别的材料已知是 非常重要的药物材料,用于广泛的医疗和农业应用以及可能的推进剂应用。

    Emulsion binders for joint compounds
    8.
    发明授权
    Emulsion binders for joint compounds 失效
    用于接合化合物的乳液粘合剂

    公开(公告)号:US4972013A

    公开(公告)日:1990-11-20

    申请号:US316715

    申请日:1989-02-28

    CPC classification number: C08K5/17 C08K5/21

    Abstract: A ready-mixed (wet) joint compound comprising a filler, binder, thickener, non-leveling agent and sufficient water to afford a viscosity that renders the joint compound usable, the binder consisting essentially of a polyvinyl alcohol-stabilized vinyl acetate/ethylene polymer emulsion, 0.1 to 10 wt % polyethoxylated tallow amine and 0.1 to 10 wt % urea, the wt % being based on emulsion solids.

    Abstract translation: 包含填料,粘合剂,增稠剂,非流平剂和足量水的预混合(湿)接头化合物,以提供可使接头化合物使用的粘度,所述粘合剂基本上由聚乙烯醇稳定的乙酸乙烯酯/乙烯聚合物 乳液,0.1至10重量%的聚乙氧基化牛脂胺和0.1至10重量%的尿素,wt%基于乳液固体。

Patent Agency Ranking